Skip to main content

Advertisement

SpringerLink
Log in

Clinicopathological Features of Insulinoma: A Single Tertiary Center Experience

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Insulinoma is a rare pancreatic neuroendocrine tumor with an incidence of 1–4 cases per million. Here we present our 10 years of experience in 13 cases of insulinoma. We retrospectively reviewed all insulinoma patients diagnosed and treated between 2012 and 2022. Clinical and pathological features, diagnostic methods, and follow-up results of insulinoma patients were discussed. A total of 13 patients were included in this study (7 men, and 6 women). The mean age at the time of diagnosis was 58 (36.5–70.5) years. There is only one patient diagnosed with MEN-1 syndrome. The mean time from the onset of symptoms to the diagnosis was 15 (7–27.5) months. In the prolonged fasting test, symptomatic hypoglycemia occurred in all patients within 48 h. The median size of lesions was 15 (12–24) mm, and 46.2% of these lesions were isolated in the pancreatic tail. Ga-68 DOTATATE PET/CT detected lesions with 100% accuracy. Three patients met the criteria for malignant insulinoma. Octreotide LAR was given to 1 patient with metastatic disease and 1 patient who did not accept surgery. The metastatic patient received 8 cycles of Lu treatment and died after 51 months of follow-up. The diagnosis of insulinoma can be challenging. The 48-h fasting test period provided sufficient information for the diagnosis of insulinoma. Ga-68 DOTATATE PET/CT may be an alternative in cases where cross-sectional imaging cannot localize the pancreatic lesion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

The datasets used are available from the corresponding author upon reasonable request.

References

  1. Service FJ, Mcmahon MM, Obrien PC, Ballard DJ (1991) Functioning Insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66:711–719. https://doi.org/10.1016/S0025-6196(12)62083-7

    Article  CAS  PubMed  Google Scholar 

  2. Sotoudehmanesh R, Hedayat A, Shirazian N et al (2007) Endoscopic ultrasonography (EUS) in the localization of insulinoma. Endocrine 31:238–241. https://doi.org/10.1007/S12020-007-0045-4/FIGURES/3

    Article  CAS  PubMed  Google Scholar 

  3. Baudin E, Caron P, Lombard-Bohas C et al (2013) Malignant insulinoma: Recommendations for characterisation and treatment Insulinome malin : caractérisation et traitement ♦. Ann Endocrinol (Paris) 74:523–533. https://doi.org/10.1016/j.ando.2013.05.009

    Article  PubMed  Google Scholar 

  4. Iglesias P, Díez JJ (2014) MANAGEMENT OF ENDOCRINE DISEASE: A clinical update on tumor-induced hypoglycemia. Eur J Endocrinol 170:R147–R157. https://doi.org/10.1530/EJE-13-1012

    Article  CAS  PubMed  Google Scholar 

  5. Okabayashi T, Shima Y, Sumiyoshi T et al (2013) Diagnosis and management of insulinoma. World J Gastroenterol 19:829–837. https://doi.org/10.3748/wjg.v19.i6.829

    Article  PubMed  PubMed Central  Google Scholar 

  6. Aydemir E, Ateş C, Saridaş FM et al (2022) Evaluation of insulinoma cases presented with hyperinsulinemic hypoglycemia: a single-centre experience. Turkish J Intern Med 4:23–28. https://doi.org/10.46310/TJIM.1073351

    Article  Google Scholar 

  7. Peltola E, Hannula P, Huhtala H et al (2018) Characteristics and outcomes of 79 patients with an Insulinoma: A nationwide retrospective study in Finland. Int J Endocrinol 2018:. https://doi.org/10.1155/2018/2059481

  8. Yu J, Ping F, Zhang H et al (n.d.) Clinical management of malignant insulinoma: a single Institution’s experience over three decades. https://doi.org/10.1186/s12902-018-0321-8

  9. Hasanov R, Samadov E, Bayramov N et al (2020) Surgical management of insulinomas at the Azerbaijan Medical University: a retrospective study of 21 cases over a 10-year period. Turkish J Med Sci 50:1262–1269. https://doi.org/10.3906/sag-2001-150

    Article  CAS  Google Scholar 

  10. Shirzad N, Ahmadi P, Shahsiah R, Hemmatabadi M (2021) Insulinoma: spectrum of clinicopathological features in a tertiary center. Istanbul Med J 22:61–67. https://doi.org/10.4274/IMJ.GALENOS.2021.45202

    Article  Google Scholar 

  11. Jyotsna VP, Pal S, Kandasamy D et al (2016) Evolving management of insulinoma: experience at a tertiary care centre. Indian J Med Res 144:771. https://doi.org/10.4103/IJMR.IJMR_1477_14

    Article  PubMed  PubMed Central  Google Scholar 

  12. Anakal MG, Kalra P, Dharmalingam M et al (2014) Insulinoma case series: experience of a tertiary care center. Indian J Endocrinol Metab 18:858. https://doi.org/10.4103/2230-8210.141385

    Article  PubMed  PubMed Central  Google Scholar 

  13. Niederle B, Selberherr A, Bartsch DK et al (2021) Multiple endocrine neoplasia type 1 and the pancreas: diagnosis and treatment of functioning and non-functioning pancreatic and duodenal neuroendocrine neoplasia within the MEN1 syndrome – an international consensus statement. Neuroendocrinology 111:609–630. https://doi.org/10.1159/000511791

    Article  CAS  PubMed  Google Scholar 

  14. Sada A, Yamashita TS, Glasgow AE et al (2021) Comparison of benign and malignant insulinoma. Am J Surg 221:437–447. https://doi.org/10.1016/J.AMJSURG.2020.08.003

    Article  PubMed  Google Scholar 

  15. Gopal RA, Acharya SV, Menon SK et al (2010) Clinical profile of insulinoma: Analysis from a tertiary care referral center in India. Indian J Gastroenterol 29:205–208. https://doi.org/10.1007/S12664-010-0051-Y/FIGURES/2

    Article  PubMed  Google Scholar 

  16. Sharma A, Varshney P, Kasliwal R et al (2022) Insulinoma—accurate preoperative localization is the key to management: an initial experience. Indian J Surg Oncol 13:403–411. https://doi.org/10.1007/S13193-022-01534-6/FIGURES/2

    Article  PubMed  PubMed Central  Google Scholar 

  17. Paul TV, Jacob JJ, Vasan SK et al (2008) Management of insulinomas: Analysis from a tertiary care referral center in India. World J Surg 32:576–582. https://doi.org/10.1007/S00268-007-9390-Y/TABLES/3

    Article  PubMed  Google Scholar 

  18. Placzkowski KA, Vella A, Thompson GB et al (2009) Secular trends in the presentation and management of functioning Insulinoma at the Mayo Clinic, 1987–2007. J Clin Endocrinol Metab 94:1069–1073. https://doi.org/10.1210/JC.2008-2031

    Article  CAS  PubMed  Google Scholar 

  19. Grant CS (2005) Insulinoma. Best Pract Res Clin Gastroenterol 19:783–798. https://doi.org/10.1016/J.BPG.2005.05.008

    Article  CAS  PubMed  Google Scholar 

  20. Prasad V, Sainz-Esteban A, Arsenic R et al (2016) Role of (68)Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study. Eur J Nucl Med Mol Imaging 43:1593–1600. https://doi.org/10.1007/S00259-016-3331-7

    Article  CAS  PubMed  Google Scholar 

  21. Nockel P, Babic B, Millo C et al (2017) Localization of Insulinoma using 68Ga-DOTATATE PET/CT Scan. J Clin Endocrinol Metab 102:195. https://doi.org/10.1210/JC.2016-3445

    Article  PubMed  Google Scholar 

  22. Shah R, Sehemby M, Garg R et al (2022) 68Ga-DOTATATE PET/CT imaging in endogenous hyperinsulinemic hypoglycemia: A tertiary endocrine centre experience. Clin Endocrinol (Oxf) 96:190–199. https://doi.org/10.1111/CEN.14586

    Article  CAS  PubMed  Google Scholar 

  23. Partelli S, Bartsch DK, Capdevila J et al (2017) ENETS consensus guidelines for the standards of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinology 105:255–265. https://doi.org/10.1159/000464292

    Article  CAS  PubMed  Google Scholar 

  24. Nikfarjam M, Warshaw AL, Axelrod L et al (2008) Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital. Ann Surg 247:165–172. https://doi.org/10.1097/SLA.0B013E31815792ED

    Article  PubMed  Google Scholar 

  25. Zhao YP, Zhan HX, Zhang TP et al (2011) Surgical management of patients with insulinomas: result of 292 cases in a single institution. J Surg Oncol 103:169–174. https://doi.org/10.1002/JSO.21773

    Article  PubMed  Google Scholar 

  26. Mishra A, Neyaz Z, Yadav S et al (2022) Outcome of pre-operative vs intraoperative localization techniques in insulinoma: experience in a tertiary referral center. Indian J Surg: 1–6. https://doi.org/10.1007/S12262-022-03569-Z/FIGURES/2

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, Kocaeli University Faculty of Medicine, Kocaeli, Turkey

    Mehmet Sözen, Zeynep Cantürk, Alev Selek, Berrin Çetinarslan, Emre Gezer & Damla Köksalan

  2. Department of Internal Medicine, Kocaeli University Faculty of Medicine, Kocaeli, Turkey

    Baldan Huri Eryılmaz

Authors
  1. Mehmet Sözen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zeynep Cantürk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alev Selek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Berrin Çetinarslan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Baldan Huri Eryılmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Emre Gezer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Damla Köksalan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mehmet Sözen.

Ethics declarations

Consent for Publication

Not applicable.

Competing Interests

All co-authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sözen, M., Cantürk, Z., Selek, A. et al. Clinicopathological Features of Insulinoma: A Single Tertiary Center Experience. Indian J Surg Oncol 14, 564–570 (2023). https://doi.org/10.1007/s13193-023-01774-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-023-01774-0

Keywords

Search

Navigation